Attività
Vendite per attività
ILS in Milioni | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
License
96,0
%
| - | - | 17 | 96,0 % | - |
Oncology and Hematology
4,0
%
| 0 | nan % | 1 | 4,0 % | - |
Vendite per regione
ILS in Milioni | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
Israel
100,0
%
| 0 | nan % | 18 | 100,0 % | - |
Dirigenti
Dirigenti | Titolo | Età | Da |
---|---|---|---|
Philip Serlin
CEO | Chief Executive Officer | 63 | 24/05/09 |
Mali Zeevi
DFI | Director of Finance/CFO | 48 | 01/01/09 |
Irit Gliko-Kabir
CTO | Chief Tech/Sci/R&D Officer | - | 01/09/17 |
John Lacey
IRC | Investor Relations Contact | - | - |
Asaf Aloni
PRN | Corporate Officer/Principal | - | - |
Tali Yaron Dalah
AUD | Comptroller/Controller/Auditor | 46 | - |
Ella Sorani
PRN | Corporate Officer/Principal | 56 | 01/02/17 |
Holly May
PRN | Corporate Officer/Principal | - | 16/06/22 |
Corporate Officer/Principal | - | 01/08/19 |
Amministratori
Amministratori | Titolo | Età | Da |
---|---|---|---|
Sandra Panem
BRD | Director/Board Member | 77 | 24/02/14 |
Avraham Molcho
BRD | Director/Board Member | 66 | 01/01/10 |
Aharon Schwartz
CHM | Chairman | 80 | 01/01/04 |
Director/Board Member | 65 | 19/08/13 | |
Raf Hofstein
BRD | Director/Board Member | 74 | 01/01/03 |
Rami Dar
BRD | Director/Board Member | 67 | 01/07/22 |
Classe di azioni
Voto | Quantità | Flottante | Autocontrollo | Flottante totale | |
---|---|---|---|---|---|
Azione A | 1 | 1 199 089 165 | 1 194 817 450 ( 99,64 %) | 0 | 99,64 % |
Coordinate società
BioLineRx Ltd.
Modi'in Technology Park 2 HaMa'ayan Street
7177871, Modi'in
+972 8 642 9100
http://www.biolinerx.comSettore
Vendite per attività
Variaz. 1 gen. | Capi. | |
---|---|---|
-1,14% | 103 Mrd | |
+7,54% | 101 Mrd | |
+4,75% | 23,07 Mrd | |
-12,66% | 22,23 Mrd | |
-4,59% | 18,05 Mrd | |
-39,98% | 17,18 Mrd | |
-10,29% | 16,94 Mrd | |
+7,14% | 14,07 Mrd | |
+37,88% | 12,35 Mrd |